Jl Mag Rare-Earth (06680) received notice that controlling shareholder Jiang CIRRUS De pledged 20 million shares and released 20 million shares from pledge.
JL Mag Rare-Earth (06680) announced that Jiangxi JL Mag Rare-Earth Technology Co., Ltd. received a notice on September 18, 2026 from its controlling shareholder Jiangxi Ruide Enterprise Management Co., Ltd., learning that part of the shares held by Jiangxi Ruide in the Company had been pledged and that part of the shares had been released from pledge. The number of shares pledged this time was 20 million shares, and the number of shares released from pledge this time was 20 million shares.
Jl Mag Rare-Earth (06680) announced that Jiangxi Jl Mag Rare-Earth Technology Co., Ltd. received a notice on September 18, 2026 from its controlling shareholder Jiang CIRRUS De Enterprise Management Co., Ltd., learning that part of the shares held by Jiang CIRRUS De in the Company had been pledged and that part of the shares had been released from pledge. The number of shares pledged this time was 20 million shares, and the number of shares released from pledge this time was 20 million shares.
Related Articles
CU VENTURE INV (08159) proposes a share consolidation on a "20-into-1" basis.
US Stock Market Move | Optical communication stocks rise; Astera Labs (ALAB.US) gains over 7%.
LEADS BIOLABS-B(09887): Vilxin (opamtisumab, PD-L1/41BB bispecific antibody) monotherapy for advanced EP-NEC pivotal registrational Phase IIB study selected as LBA, and three studies granted preferred oral presentation eligibility
CU VENTURE INV (08159) proposes a share consolidation on a "20-into-1" basis.
US Stock Market Move | Optical communication stocks rise; Astera Labs (ALAB.US) gains over 7%.
LEADS BIOLABS-B(09887): Vilxin (opamtisumab, PD-L1/41BB bispecific antibody) monotherapy for advanced EP-NEC pivotal registrational Phase IIB study selected as LBA, and three studies granted preferred oral presentation eligibility
RECOMMEND
